Health1 month ago
GSK Expands Immunology Portfolio with $2.2B Rapt Therapeutics Acquisition
GlaxoSmithKline (GSK) has announced its acquisition of Rapt Therapeutics for approximately $2.2 billion, marking a significant expansion in its immunology division. This strategic move aims to...
